Potential speaker for Infectious Diseases conferences 2020
Keynote Presentation
Flavodoxins as drug targets. Novel Helicobacter pylori specific antimicrobials
Javier Sancho, University of Zaragoza, Spain

Antimicrobial resistance constitutes a global health challenge that must be met by developing novel therapeutic tools. Flavodoxins are small bacterial proteins that participate in many key metabolic pathways and are promising targets for the development of novel antimicrobials against pathogenic bacteria. The main structural and biochemical feature [....]

Potential speaker for Infectious Diseases conferences 2020
Keynote Presentation
Non-typhoidal Salmonella: Why Should We Care?
Manal Mohammed, University of Westminster, UK

Non-typhoidal Salmonella (NTS) Dublin has adapted to cause invasive illness in humans. There is no vaccine against iNTS and disease management is further complicated by the emergence of multidrug resistant (MDR) strains. It is estimated that invasive non-typhoidal Salmonella (iNTS) serovars cause over 680,000 human deaths per year. We apply next ge [....]

Potential speaker for Infectious Diseases conferences 2020
Keynote Presentation
Direct evidence of viral infection and mitochondrial alterations in the brain of fetuses at high risk for schizophrenia
Segundo Mesa Castillo, Psychiatric Hospital of Havana, Cuba

There is increasing evidences that favor the prenatal beginning of schizophrenia. These evidences point toward intra-uterine environmental factors that act specifically during the second pregnancy trimester producing a direct damage of the brain of the fetus [1]. The current available technology doesn't allow observing what is happening at cell [....]

Potential speaker for Infectious Diseases conferences 2020
Oral Presentation
Medical ozone therapy as the effective treatment for Ebola and AIDs
Sorush Niknamian, University of Cambridge, USA

Ebola is a virus. It incubates for 2 to 21 days and then roars to life to induce death. Ebola first tricks the immune system into thinking nothing is there. The virus enters many different types of cells in the human body. It multiplies extremely rapidly, emerges from the cell to infect yet more. Interestingly, much of the damage induced by the inf [....]

Potential speaker for Infectious Diseases conferences 2020
Oral Presentation
Zoonotic Tuberculosis: Characterization of Antibody Responses in Various Host Species for Improved Serodiagnosis
Konstantin Lyashchenko, Chembio Diagnostic Systems, Inc., USA

Bovine tuberculosis (bTB) has a broad range of mammalian host species including various livestock and wildlife animals. Ante-mortem testing for bTB traditionally relies on cell-mediated immune responses, such as tuberculin skin test reactions or in vitro interferon-gamma release. However, serological methods using novel antigens and advanced assay [....]

Potential speaker for Infectious Diseases conferences 2020
Oral Presentation
Combined Tuberculosis/HIV infection in Russia: Current status and perspectives
Erzheny Tsybikova, Federal Research Institute for Health Organization, Russia

Objective: Epidemiology of combined TB/HIV infection in the Russian Federation over the past 10 years (2009-2018). Materials and methods: retrospective analysis of statistical data received from the reporting forms of the ROSSTAT and MoH of Russia for the period (2009-2018). For the analysis, cartographic and correlation analyses were used. R [....]

Potential speaker for Infectious Diseases conferences 2020
Oral Presentation
Potential for spread of Leishmania tropica in southern Europe by local sand flies
Petr Volf, Charles University, Czech Republic

Various Leishmania species constitute an important global health problem with millions of people affected. Leishmania tropica is the causative agent of cutaneous leishmaniases (CL) in the Old World, occurring in many countries of Asia and Africa. Currently, a great concern is posed by outbreaks of CL in the Middle East, connected with people displa [....]

Potential speaker for Infectious Diseases conferences 2020
Oral Presentation
Sepsis as a metabolic adaptation failure
Claude Libert, Center for Inflammation Research, Belgium

Sepsis is a most deadly unmet medical need. It hits 30 million people yearly, leading to 8 million deaths, amongst which 3 million children. Usually, sepsis starts with a serious (bacterial) infection that spreads and triggers many systems of the host, including inflammation, immunity, coagulation, complement, but also thermoregulation, circadian r [....]

Potential speaker for Infectious Diseases conferences 2020
Keynote Presentation
New technologies using blood immune cells in inform on human disease status
John J Miles, James Cook University, Australia

The human immune system is a hugely complex network of cell types relentlessly communicating on host health through direct recognition and secreted compounds. We have recently found that listening to this immune cell “chatter” through phenotyping or molecular typing can inform pathology in rapid time using high-dimensional analysis and [....]

Potential speaker for Infectious Diseases conferences 2020
Keynote Presentation
Training program established by the Institutional Committee for the Care and Use of Laboratory Animals (IACUC) in pre-clinical trials on infectious diseases
Mario Enrique Garcia Rodriguez, Institute of Tropical Medicine Pedro Kouri, Cuba

The implementation in our institution, Regional Reference Center for the study of Tropical Diseases, of the Institutional Committee for the Care and Use of Laboratory Animals (IACUC), meant a change in the institutional approach in research with laboratory animals due to the need to respect the welfare of animals in the study of preclinical researc [....]

Potential speaker for Infectious Diseases conferences 2020
Keynote Presentation
Comparative study of some pharmacological activities of heterocyclic compounds derived from spiro-isoxazoline, triazole, tetrazole, pyrazole and tryptophan
Anouar Alami, Sidi Mohamed Ben Abdellah University, Morocco

The chemistry of the heterocycles constitutes one of the research themes very studied and developed in organic synthesis. Many heterocyclic derivatives are found to exhibit various biochemical, agro-chemical and electrochemical activities [1]. In continuation of our research interest in heterocyclic compounds and those precursors, we report in t [....]

Potential speaker for Infectious Diseases conferences 2020
Keynote Presentation
Infections in decompensated liver disease patients, a review of the literature
Sarah El-Nakeep, Ain Shams University, Egypt

Decompensated liver disease is a huge burden on countries that suffer from high rates of chronic hepatitis or alcoholism, also recently NASH entered in the strong contenders after the regression of chronic HCV with oral direct antivirals. Liver decompensation in the form of hepatocellular or vascular decompensation carries the risk of disturbed imm [....]

Potential speaker for Infectious Diseases conferences 2020
Keynote Presentation
Prevalence and resistance profile from ESKAPE bacteria group in a third level hospital
Maria Guadalupe Cordova Espinoza, National School of Biological Sciences, Mexico

Bacterial infections are worldwide problem health. Bacterial infections are described as the proliferation of harmful bacteria on or inside the body. There is a long list of infections among pneumonia, meningitis, sexually transmitted, bacterial skin infections, respiratory infections or nosocomial infections. Nosocomial infections or healthcare-as [....]

Potential speaker for Infectious Diseases conferences 2020
Oral Presentation
Infections caused by antibiotic-resistant ESKAPE group in Mexico
Silvia Giono Cerezo, National Polytechnic Institute, Mexico

Infections caused by antibiotic-resistant ESKAPE group microorganisms possess high risk to patients' lives, because  treatment is limited to few therapeutic options. The resistance mechanisms are: production of Extended Spectrum Lactamases (BLEE), Carbapenemes type MBL, enzymatic production of aminoglycoside resistance (HLRA), resistance t [....]

Potential speaker for Infectious Diseases conferences 2020
Poster Presentation
Human Single-Chain Antibodies to ETA: Potential Therapeutic Agent against Pseudomonal Infection
Sirijan Santajit, Mahidol University, Thailand

Pseudomonas exotoxin A (ETA) is the most potent virulence determinant produced by Pseudomonas aeruginosa which is one of the foremost causes of life-threatening nosocomial infections. The ETA catalyzes the ADP-ribosylation of eukaryotic elongation factor-2 halting protein synthesis and leading to mammalian cell death. Engineered single-chain antibo [....]

Potential speaker for Infectious Diseases conferences 2020
Poster Presentation
Characteristic analysis for clinical isolates of Pseudomonas aeruginosa NCCP strains from Korea
Joon Ki Kim, Korea National Institute of Health, Republic of Korea

Pseudomonas aeruginosa could be infected almost body tissues and is known to cause skin infections, endocarditis, pneumonia and bacteremia, sepsis diseases. National Culture Collection for Pathogens (NCCP) in Korea is to distribute pathogen resources and provide their various information of quality assured to use to disease diagnostic researches [....]

Potential speaker for Infectious Diseases conferences 2020
Poster Presentation
Molecular and Biochemical Characterization of Escherichia coli NCCP strains in Korea
Suyeon Kim, Korea National Institute of Health, Republic of Korea

The National Culture Collection for Pathogens (NCCP) is the biobank of the Korea Centers for Disease Control & Prevention and has a variety of clinically isolated pathogens from Korea. The NCCP strives to contribute to healthcare industries with its characterized strains. The informative characteristics of each resource are used to research, [....]

Potential speaker for Infectious Diseases conferences 2020
Poster Presentation
Viral pathogens associated with acute lower respiratory tract infections in Bulgaria
Ivelina Trifonva, National Centre of Infectious and Parasitic Diseases, Bulgaria

Acute lower respiratory tract infections are a major cause of morbidity and hospital admissions. This study aimed to determine the viral etiology of these infections among the patients of different age groups in Bulgaria during the period October 2016-September 2019. Nasopharyngeal specimens were collected from patients with bronchiolitis, pneumoni [....]

Potential speaker for Infectious Diseases conferences 2020
Poster Presentation
Study of Patterns and Markers of Human Immune Deficiency Virus -1 (HIV-1) Progression and Unemployment Rate among Patients from Alexandria, Egypt
Sarah Magdy Abdelhamid, Damanhour University, Egypt

The Middle East and North Africa (MENA) new HIV cases show the highest increase among all regions in the world. Even though Egypt has a low prevalence among the general population (< 0.02%), a national HIV epidemic occurs in certain population risk groups. The current study was conducted to asses clinical and immunological disease progression; f [....]

Potential speaker for Infectious Diseases conferences 2020
Poster Presentation
Standardization of a pncA Gene Complementation Technique in Mycobacterium tuberculosis pncA-knockout: Tool for the Study of the Relationship Between Mutations in pncA and Phenotypic Parameters
Yudith Cauna Orocollo, Universidad Peruana Cayetano Heredia, Peru

Mutations in the pncA gene are the major cause of resistance to pyrazinamide (PZA), but there are alternative mechanisms that also provide resistance. The objective of the study was to standardize the pncA gene complementation technique in Mycobacterium tuberculosis H37Rv pncA-knockout to evaluate the effect of mutations in the pncA gene, in a scen [....]

Potential speaker for Infectious Diseases conferences 2020
Poster Presentation
Diagnostic utility of bronchoalveolar lavage and computerized tomography in diagnosis of recurrence among sputum scarce and sputum negative treated pulmonary tuberculosis suspects
Pankaj Jorwal, All India Institute of Medical Sciences, India

Objective: There are a large number of patients who present with chest symptoms of short duration at secondary and tertiary care centers with a background history of anti-tubercular therapy in the past. The literature regarding the evaluation and management of such patients is scarce. Therefore a study was planned with the aim of to assess the sens [....]

Keynote Speaker For Infectious Diseases Conference 2020 - Katja Fischer
Keynote Presentation
Global exploration of scabies-associated microbiota: a multi-country, observational cross-sectional analysis to understand the pathobiology of impetigo linked to scabies
Katja Fischer, QIMR Berghofer Medical Research Institute, Australia

Globally, scabies causes substantial morbidity and mortality. In the tropics, scabies frequently promotes opportunistic bacterial infections, leading to cellulitis/necrotizing fasciitis, bacteraemia, kidney disease and/or rheumatic heart disease. With no vaccine, diagnostic tools and limited treatment options, scabies is considered neglected by WHO [....]

Potential speaker for Infectious Diseases conferences 2020
Poster Presentation
Molecular drug susceptibility testing and genotyping of Neisseria gonorrhoeae isolates in Russia
Ilya Kandinov, Russian Academy of Sciences, Russian Federation

Gonococcal infection belongs to the most common sexually transmitted infections. Due to the developing antimicrobial resistance, in particular, resistance to fluoroquinolones and 3rd generation cephalosporins, Neisseria gonorrhoeae is considered to be a high priority pathogen according to the WHO list. In this work, we analyzed 270 N. gonorrhoea [....]

Potential speaker for Infectious Diseases conferences 2020
Poster Presentation
Genetic and biochemical equivalent characterization for Staphylococcus and Micrococcus NCCP resources as reference strains
Yewon An, Korea National Institute of Health, Republic of Korea

Bacterial pathogens have been used during quality control while developing medicine, cosmetics, and feed in healthcare and industrial fields worldwide. Some countries including America, China, and Japan, as well as a few from Europe, have their own pharmacopoeias and they approve medical supplies that have undergone quality assurance based on steri [....]

Potential speaker for Infectious Diseases conferences 2020
Oral Presentation
Primary health care: a challenge for infection control
Eliane Patricia Lino Pereira Franchi, Universidade Federal do Tocantins- UFT, Brazil

The World Health Organization has placed patient safety as a high priority on the agenda, being the first challenge to reduce healthcare-associated infections (HAIs). HAIs are considered undesirable events arising out of the process of health care and represent a major concern for global public health. These infections prolong the length of hospita [....]

Potential speaker for Infectious Diseases conferences 2020
Oral Presentation
Prevalence of toxoplasmosis in populations of Tlacuaches (Didelphis albiventris), in the municipality of Morelia and its zoonotic relationship
Hector Javier Gallardo Valencia, Michoacana University, Mexico

Zoonotic diseases have always been of concern to humans, one of the most common is toxoplasmosis, a worldwide disease caused by the etiological agent Toxoplasma gondii (Carrada, 2005), which affects birds, mammals and man, Basso and Venturini (2009) mention that: “The infection has a variable clinical presentation according to the affect [....]

Potential speaker for Infectious Diseases conferences 2020
Oral Presentation
Diagnostic role of cerebrospinal lactate dehydrogenase and serum procalcitonin in meningitis in beni-suiefe governorate
Sayed farouk mohamed , University of Al-Azhar, Egypt

Background: Meningitis means the membranes that cover the brain, spinal cord, and the intervening cerebrospinal fluid becomes inflamed  as a result of  infection of cerebrospinal fluid by a variety of infectious agents. Acute meningitis is caused by a variety of infectious agents. The most serious form is caused by pyogenic bacteria, [....]

Potential speaker for Infectious Diseases conferences 2020
Oral Presentation
Potential serum biomarkers for early detection of diabetic nephropathy
Tarek M K Metawie, Cairo University, Egypt

Aim: Diabetic nephropathy (DN) is considered as one of the diabetic complications affecting up to 40% of patients with type 1 or type 2 diabetes. In clinical practice, the frequently used markers of renal disease and progression are serum creatinine, estimated glomerular filtration rate (eGFR) and albuminuria. The aim of this study is to [....]

Potential speaker for Infectious Diseases conferences 2020
Oral Presentation
An Observational Analytical Retrospective Study on the Profile of Adenoviral Infection among Children Admitted In a Tertiary Care Centre in Eastern India
Sumon Poddar, Institute of Child Health, India

Human adenovirus (HAdV) causes upper and lower respiratory tract infections. However, there are few large prospective studies focused on HAdVs acute infections requiring hospitalization. A retrospective study was conducted on children admitted with acute respiratory infections with PCR positive adeno virus at Institute of Child Health, Kolkata from [....]

Potential speaker for Infectious Diseases conferences 2020
Oral Presentation
Impact of optimizing antibiotic prophylaxis policy on surgical site infections
Debkishore Gupta, C K Birla Hospitals, India

Administration of prophylactic antibiotics is a standard practice before cardiac surgeries. The previously recommended prophylactic antibiotics for cardiac surgeries were Cefuroxime and Levofloxacin. Patients were monitored up to three months post-surgery ascertained through routine infection control surveillance using the National Healthcare Safet [....]

Watsapp